Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy
Clinical trial NCT02517320 · COMPLETED
Trial details
- NCT number
- NCT02517320
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-11-01
- Enrollment
- 293
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.